These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8388765)
1. Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Little MH; Williamson KA; Mannens M; Kelsey A; Gosden C; Hastie ND; van Heyningen V Hum Mol Genet; 1993 Mar; 2(3):259-64. PubMed ID: 8388765 [TBL] [Abstract][Full Text] [Related]
2. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1. Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912 [TBL] [Abstract][Full Text] [Related]
3. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin. Nordenskjöld A; Friedman E; Anvret M Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732 [TBL] [Abstract][Full Text] [Related]
4. The same mutation affecting the splicing of WT1 gene is present on Frasier syndrome patients with or without Wilms' tumor. Barbosa AS; Hadjiathanasiou CG; Theodoridis C; Papathanasiou A; Tar A; Merksz M; Györvári B; Sultan C; Dumas R; Jaubert F; Niaudet P; Moreira-Filho CA; Cotinot C; Fellous M Hum Mutat; 1999; 13(2):146-53. PubMed ID: 10094551 [TBL] [Abstract][Full Text] [Related]
5. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations. Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587 [TBL] [Abstract][Full Text] [Related]
6. A point mutation found in the WT1 gene in a sporadic Wilms' tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. Akasaka Y; Kikuchi H; Nagai T; Hiraoka N; Kato S; Hata J FEBS Lett; 1993 Feb; 317(1-2):39-43. PubMed ID: 8381368 [TBL] [Abstract][Full Text] [Related]
7. A zinc finger truncation of murine WT1 results in the characteristic urogenital abnormalities of Denys-Drash syndrome. Patek CE; Little MH; Fleming S; Miles C; Charlieu JP; Clarke AR; Miyagawa K; Christie S; Doig J; Harrison DJ; Porteous DJ; Brookes AJ; Hooper ML; Hastie ND Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2931-6. PubMed ID: 10077614 [TBL] [Abstract][Full Text] [Related]
8. Mutational screening of the Wilms's tumour gene, WT1, in males with genital abnormalities. Clarkson PA; Davies HR; Williams DM; Chaudhary R; Hughes IA; Patterson MN J Med Genet; 1993 Sep; 30(9):767-72. PubMed ID: 8411073 [TBL] [Abstract][Full Text] [Related]
9. Identification of constitutional WT1 mutations, in patients with isolated diffuse mesangial sclerosis, and analysis of genotype/phenotype correlations by use of a computerized mutation database. Jeanpierre C; Denamur E; Henry I; Cabanis MO; Luce S; Cécille A; Elion J; Peuchmaur M; Loirat C; Niaudet P; Gubler MC; Junien C Am J Hum Genet; 1998 Apr; 62(4):824-33. PubMed ID: 9529364 [TBL] [Abstract][Full Text] [Related]
10. Nephropathy with Wilms tumour or gonadal dysgenesis: incomplete Denys-Drash syndrome or separate diseases? Schmitt K; Zabel B; Tulzer G; Eitelberger F; Pelletier J Eur J Pediatr; 1995 Jul; 154(7):577-81. PubMed ID: 7556327 [TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of two female patients with incomplete Denys-Drash syndrome. Ohta S; Ozawa T; Shiraga H; Fuse H Endocr J; 2000 Dec; 47(6):683-7. PubMed ID: 11228042 [TBL] [Abstract][Full Text] [Related]
12. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Pelletier J; Bruening W; Kashtan CE; Mauer SM; Manivel JC; Striegel JE; Houghton DC; Junien C; Habib R; Fouser L Cell; 1991 Oct; 67(2):437-47. PubMed ID: 1655284 [TBL] [Abstract][Full Text] [Related]
13. Inherited WT1 mutation in Denys-Drash syndrome. Coppes MJ; Liefers GJ; Higuchi M; Zinn AB; Balfe JW; Williams BR Cancer Res; 1992 Nov; 52(21):6125-8. PubMed ID: 1327525 [TBL] [Abstract][Full Text] [Related]
15. Role for first zinc finger of WT1 in DNA sequence specificity: Denys-Drash syndrome-associated WT1 mutant in ZF1 enhances affinity for a subset of WT1 binding sites. Wang D; Horton JR; Zheng Y; Blumenthal RM; Zhang X; Cheng X Nucleic Acids Res; 2018 May; 46(8):3864-3877. PubMed ID: 29294058 [TBL] [Abstract][Full Text] [Related]
16. Genotype/phenotype correlations in Wilms' tumor. Huff V Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067 [TBL] [Abstract][Full Text] [Related]
17. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation. Machin GA Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334 [No Abstract] [Full Text] [Related]
18. A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome. Little S; Hanks S; King-Underwood L; Picton S; Cullinane C; Rapley E; Rahman N; Pritchard-Jones K Pediatr Nephrol; 2005 Jan; 20(1):81-5. PubMed ID: 15503171 [TBL] [Abstract][Full Text] [Related]
19. Prophylactic bilateral nephrectomies in two paediatric patients with missense mutations in the WT1 gene. Hu M; Zhang GY; Arbuckle S; Graf N; Shun A; Silink M; Lewis D; Alexander SI Nephrol Dial Transplant; 2004 Jan; 19(1):223-6. PubMed ID: 14671061 [TBL] [Abstract][Full Text] [Related]
20. Association of partial gonadal dysgenesis, nephropathy and WT1 gene mutation without Wilms' tumor: incomplete Denys-Drash syndrome. Cetinkaya E; Ocal G; Berberoğlu M; Adiyaman P; Ekim M; Yalçinkaya F; Orün E J Pediatr Endocrinol Metab; 2001 May; 14(5):561-4. PubMed ID: 11393579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]